UBE2C and non-small cell lung carcinoma: The purpose of this work, therefore, was to investigate whether different UbcH10 levels are linked to resistance to TKI treatment and to determine why UbcH10 levels are lower in NSCLC with EGFR mutations compared with EGFR-WT tumors.